Patents by Inventor Carlo Soranzo

Carlo Soranzo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields
    Patent number: 8349355
    Abstract: The present invention relates to novel formulations comprising lipoic acid and hyaluronic acid and/or the derivatives thereof for use in the repair of chronic ulcers, the regeneration of damaged skin, the prevention of skin aging and, when administered by the systemic route, to treat peripheral neuropathies and intoxications by chemical and/or biological agents.
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: January 8, 2013
    Assignee: Anika Therapeutics S.R.L.
    Inventors: Carlo Soranzo, Doriana Senigaglia, Davide Bellini
  • Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields
    Publication number: 20090304758
    Abstract: The present invention relates to novel formulations comprising lipoic acid and hyaluronic acid and/or the derivatives thereof for use in the repair of chronic ulcers, the regeneration of damaged skin, the prevention of skin aging and, when administered by the systemic route, to treat peripheral neuropathies and intoxications by chemical and/or biological agents.
    Type: Application
    Filed: May 24, 2006
    Publication date: December 10, 2009
    Inventors: Carlo Soranzo, Doriana Senigaglia, Davide Bellini
  • Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives
    Patent number: 6110208
    Abstract: Artificial human skin is disclosed which is based on: (a) a microperforated membrane based on a hyaluronic acid derivative on which keratinocytes have been seeded and cultured; (b) an underlying non-woven tissue based on a hyaluronic acid derivative wherein fibroblasts have been seeded and left to proliferate.The artificial human skin may be used in medical, surgical, diagnostic and controlled release drug delivery applications. The artificial human skin may be safely frozen to -80.degree. C. or stored in liquid nitrogen in order to have a skin tissue bank.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: August 29, 2000
    Assignee: Fidia Advanced Biopolymers S.R.L
    Inventors: Carlo Soranzo, Giovanni Abatangelo, Lanfranco Callegaro